Separation of liposome-entrapped mitoxantrone from nonliposomal mitoxantrone in plasma: Pharmacokinetics in mice

Methods in Enzymology

Volumn 391, Issue SPEC. ISS., 2005, Pages 176-185

  Ahmad, Ateeq ^a   Wang, Yue Fen ^a   Ahmad, Imran ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; METHANOL; MITOXANTRONE; SILICA GEL;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG ISOLATION; DRUG SENSITIVITY; DRUG SYNTHESIS; FREEZE THAWING; HYDROPHOBICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SUSTAINED DRUG RELEASE;

ANIMALIA;

EID: 13844266185     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(05)91010-0     Document Type: Article

References (13)

1. Bellott R., Pouna P., Robert J. Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome. J. Chromatogr. B. 757:2001;257-267
2. Bonte F., Juliano R.L. Interactions of liposomes with serum proteins. Chem. Phys. Lipids. 40:1986;359-372
3. Chonn A., Semple S.C., Cullis P.R. Separation of large unilamellar liposomes from blood components by a spin column procedure: Towards identifying plasma proteins which mediate liposome clearance in vivo. Biochim. Biophys. Acta. 1070:1991;215-222
4. Cullis P.R., Mayer L.D., Bally M.B., Madden T.D., Hope M.J. Generating and loading of liposomal systems for drug-delivery applications. Adv. Drug Delivery Rev. 3:1989;267-282
5. Druckman S., Gabizon G., Barenholz Y. Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: Implications for pharmacokinetic studies. Biochim. Biophys. Acta. 980:1989;381-384
6. Gokhale P.C., Pei J., Zhang C., Ahmad I., Rahman A., Kasid U. Improved safety, pharmacokinetics, and therapeutic efficacy profiles of a novel liposomal formulation of mitoxantrone. Anticancer Res. 21:2001;3313-3321
7. Krishna R., Webb M., St.-Onge G.S., Mayer L.D. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties. J. Pharmacol. Exp. Ther. 298:2001;1206-1212
8. Mayer L.D., St.-Onge G. Determination of Free and Liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques. Anal. Biochem. 232:1995;149-157
9. Ostro M.J., Cullis P.R. Use of liposomes as injectable-drug delivery systems. Am. J. Hosp. Pharm. 46:1989;1576-1587
10. Priston M.J., Sewell G.J. Improved LC assay for the determination of mitozantrone in plasma: Analytical considerations. J. Pharm. Biomed. Anal. 12:1994;1153-1162
11. Senior J. Fate and behavior of liposomes in vivo: A review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3:1987;123-193
12. Srigritsanapol A.A., Chan K.K. A rapid method for the separation and analysis of leaked and liposomal entrapped phosphoramide mustard in plasma. J. Pharm. Biomed. Anal. 12:1994;961-968
13. Thies R.L., Cowens D.W., Cullis P.R., Bally M.B., Mayer L.D. Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma. Anal. Biochem. 188:1990;65-71